Anti-TNNI1 antibody [EPR17120-11]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal TNNI1 antibody. Suitable for IP, WB, IHC-P and reacts with Human samples. Cited in 3 publications.
View Alternative Names
TNNI1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNNI1 antibody [EPR17120-11] (AB203515)
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling TNNI1 with ab203515 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. No staining on Human kidney tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNNI1 antibody [EPR17120-11] (AB203515)
Immunohistochemical analysis of paraffin-embedded Human skeletal muscle tissue labeling TNNI1 with ab203515 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) secondary antibody at 1/500 dilution. Cytoplasmic staining on striated Human skeletal muscle tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-TNNI1 antibody [EPR17120-11] (AB203515)
TNNI1 was immunoprecipitated from 1mg of Human fetal heart whole cell lysate with ab203515 at 1/40 dilution. Western blot was performed from the immunoprecipitate using ab203515 at 1/1000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : Human fetal heart whole cell lysate 10 μg (Input). Lane 2 : ab203515 IP in Human fetal heart whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab203515 in Human fetal heart whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 1 second.
All lanes:
Immunoprecipitation - Anti-TNNI1 antibody [EPR17120-11] (ab203515)
Predicted band size: 22 kDa
false
- WB
Supplier Data
Western blot - Anti-TNNI1 antibody [EPR17120-11] (AB203515)
Blocking/Dilution buffer : 5% NFDM/TBST.
TNNI1 is abundantly expressed in the human skeletal muscle and heart.
All lanes:
Western blot - Anti-TNNI1 antibody [EPR17120-11] (ab203515) at 1/2000 dilution
Lane 1:
Human fetal heart tissue lysate at 10 µg
Lane 2:
Human fetal kidney tissue lysate at 10 µg
Lane 3:
U-87 MG (Human glioblastoma-astrocytoma epithelial cell line) cell lysate at 10 µg
Lane 4:
HepG2 (Human liver hepatocellular carcinoma) cell lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/50000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
Exposure time: 5s
- WB
Supplier Data
Western blot - Anti-TNNI1 antibody [EPR17120-11] (AB203515)
Blocking/Dilution buffer : 5% NFDM/TBST.
TNNI1 is abundantly expressed in the human skeletal muscle and heart.
All lanes:
Western blot - Anti-TNNI1 antibody [EPR17120-11] (ab203515) at 1/2000 dilution
All lanes:
Human skeletal muscle tissue lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/50000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
Exposure time: 5s
Related conjugates and formulations (1)
-
Anti-TNNI1 antibody [EPR17120-11] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:8291 PubMed40957896
2025
Applications
Unspecified application
Species
Unspecified reactive species
Development, growth & differentiation 66:119-132 PubMed38193576
2024
Applications
Unspecified application
Species
Unspecified reactive species
NPJ Regenerative medicine 7:14 PubMed35110584
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com